Follow
Aprameya Ganesh Prasad
Aprameya Ganesh Prasad
Other namesAprameya Prasad
Scientist at Johnson & Johnson
Verified email at its.jnj.com - Homepage
Title
Cited by
Cited by
Year
Growth of metastatic triple-negative breast cancer is inhibited by deep tumor-penetrating and slow tumor-clearing chemotherapy: the case of tumor-adhering liposomes with …
S Stras, A Howe, A Prasad, D Salerno, O Bhatavdekar, S Sofou
Molecular pharmaceutics 17 (1), 118-131, 2019
262019
Transport-driven engineering of liposomes for delivery of α-particle radiotherapy to solid tumors: effect on inhibition of tumor progression and onset delay of spontaneous …
A Prasad, R Nair, O Bhatavdekar, A Howe, D Salerno, M Sempkowski, ...
European Journal of Nuclear Medicine and Molecular Imaging 48 (13), 4246-4258, 2021
172021
Predicting response of micrometastases with MIRDcell V3: proof of principle with 225Ac-DOTA encapsulating liposomes that produce different activity distributions …
S Katugampola, J Wang, A Prasad, S Sofou, RW Howell
European journal of nuclear medicine and molecular imaging 49 (12), 3989-3999, 2022
52022
Development of a spectrophotometric biphasic assay for the estimation of mPEG-maleimide in thiol PEGylation reaction mixtures
P Nanda, PE Jagadeeshbabu, P Gupta, AG Prasad
Chemical Engineering Communications 203 (11), 1464-1472, 2016
32016
Combined, yet Separate: cocktails of carriers (not drugs) for α-particle therapy of solid tumors expressing moderate-to-low levels of targetable markers
R Nair, A Prasad, O Bhatavdekar, A Sarkar, KL Gabrielson, S Sofou
bioRxiv, 2023.07. 31.551152, 2023
12023
Surface-Functionalized Polymeric Nanoparticles for Breast Cancer Treatment: Processes and Advances
A Prasad, MM Bakr, AN ElMeshad
Journal of Drug Targeting, 1-28, 2024
2024
Combined, yet separate: cocktails of carriers (not drugs) for actinium-225 α-particle therapy of solid tumors expressing moderate-to-low levels of targetable markers
RR Nair, A Prasad, O Bhatavdekar, A Sarkar, KL Gabrielson, S Sofou
European Journal of Nuclear Medicine and Molecular Imaging, 1-14, 2024
2024
State-of-the-art drug delivery system to target the lymphatics
OT Khaire, A Mhaske, AG Prasad, WH Almalki, N Srivastava, ...
Journal of Drug Targeting, 1-34, 2024
2024
Toxic effects of cancer therapies
S Ingole, N Vasdev, M Tekade, T Gupta, B Pawar, M Mhatre, AG Prasad, ...
Public Health and Toxicology Issues Drug Research, Volume 2, 353-379, 2024
2024
Design of toxicokinetic studies
S Kaur, M Tekade, N Vasdev, B Pawar, T Gupta, AG Prasad, RK Tekade
Public Health and Toxicology Issues Drug Research, Volume 2, 205-224, 2024
2024
Radiotherapy toxicity
M Panchal, S Mule, Y Wankhede, M Tekade, T Gupta, AG Prasad, ...
Public Health and Toxicology Issues Drug Research, Volume 2, 617-647, 2024
2024
Adhesive/adsorption switch on nanoparticles to increase tumor uptake and delay tumor clearance
S Sofou, SS Stras, A Howe, AG Prasad, D Salerno
US Patent App. 17/422,667, 2022
2022
ALPHA-PARTICLE NANOTHERAPEUTICS AGAINST METASTATIC AND/OR CHEMORESISTANT TRIPLE NEGATIVE BREAST CANCER
AG Prasad
Johns Hopkins University, 2022
2022
Alpha-Particle Nanotherapeutics Against Metastatic Triple Negative Breast Cancer
AG Prasad, S Sofou
2021 AIChE Annual Meeting, 2021
2021
MIRDcell v3. 01 Predicts Response of Nonuniform Distribution of Ac-225 labeled Nanocarriers in Multicellular Tumor Spheroids
S Katugampola, J Wang, A Prasad, S Sofou, R Howell
Journal of Nuclear Medicine 62 (supplement 1), 1576-1576, 2021
2021
Alpha-particle Nanotherapeutics Against Recurrent, Metastatic Triple Negative Breast Cancer
AG Prasad, S Sofou
Journal of Nuclear Medicine 62 (supplement 1), 1275-1275, 2021
2021
Diffusion-Based Delivery of Alpha-Particle Radiotherapeutics Effectively Controls Recurrent, Chemoresistant Triple Negative Breast Cancer
S Sofou, AG Prasad
2019 AIChE Annual Meeting, 2019
2019
Location-Location-Location: Designing Cationic Charge Placement on Lipid Vesicles Determines their Interactions with Living Cells
AG Prasad, D Salerno, AK Howe, OM Bhatavdekar, S Sofou
Biophysical Journal 116 (3), 296a, 2019
2019
Growth Rate Dissipation of Metastatic Triple Negative Breast Cancer Attributed to Slow Tumor-Clearing and Deep Tumor-Penetrating Chemotherapy
A Howe, S Stras, AG Prasad, S Sofou
2018 AIChE Annual Meeting, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–19